To access this element change to forms mode OFF
Grant Award View - GA353592
Developing a next generation dendritic cell therapy for solid tumours
GA ID:
GA353592
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
24-Aug-2023
Publish Date:
22-Jan-2024
Category:
Medical Research
Grant Term:
1-Jan-2024 to 31-Dec-2028
Value (AUD):
$750,091.32
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 22/23 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Developing a next generation dendritic cell therapy for solid tumours
Purpose:
Cellular therapies are designed to boost the patient's immune system to better fight cancer. Dendritic cells (DCs) are sentinel cells whose normal function is to alert the immune system to infection or cancer. We are developing a method to engineer DCs that we aim to deliver to patients as a new class of cell therapy. In this project we aim to produce enough supportive data to progress this therapy towards a clinical trial in solid cancer patients.
GO ID:
GO Title:
Investigator Grants 2023
Internal Reference ID:
2023/GNT2025614
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA